What Affects IVF Success: A Guide to the Factors That Actually Matter

IVF success is not uniform and it is not random. It is shaped by a combination of biological, clinical, and lifestyle factors, some of which are within your influence and some of which are not. Understanding what actually matters — and what the evidence actually shows — helps couples engage with their treatment more realistically, make better decisions about options like genetic testing and frozen versus fresh transfers, and avoid both excessive self-blame when cycles fail and false confidence when initial indicators are favorable.

AGE AND EGG QUALITY: THE FACTOR THAT MATTERS MOST

The most consistent and powerful predictor of IVF success is the age of the woman providing the eggs — not because of the chronological age itself, but because of what age represents in terms of egg quality. Egg quality declines with age in ways that affect both the likelihood of successful fertilization and the chromosomal health of resulting embryos. This decline is gradual through the mid-thirties and becomes more pronounced after approximately 37 to 38, accelerating again after 40.

The CDC and SART publish annual outcome data that shows this age-related pattern clearly. Per-cycle live birth rates are highest for women in their twenties and early thirties, decline through the late thirties, and drop substantially after 40 for cycles using the woman's own eggs. Specific current percentages should be verified directly at sart.org — I cannot state current figures with confidence as these reports update annually and my knowledge may not reflect the most recent data.

For women over 40 or those with significantly diminished ovarian reserve, reproductive endocrinologists often discuss the option of using donor eggs, which substantially improves success rates because the eggs come from younger donors. This is a conversation worth having directly with your doctor if age or ovarian reserve is a factor in your situation, rather than waiting for the doctor to raise it.

DIAGNOSIS AND UNDERLYING MEDICAL FACTORS

The specific cause of infertility affects IVF outcomes in ways that vary considerably by diagnosis. Couples with unexplained infertility or mild male factor often have relatively favorable prognoses with IVF compared to couples with more complex diagnoses. Significant endometriosis, severely diminished ovarian reserve, or severe sperm abnormalities present greater challenges, though IVF with ICSI has substantially expanded what is possible in cases of severe male factor infertility.

A thorough diagnostic evaluation before starting IVF is one of the most valuable things a couple can do — not to accumulate information for its own sake, but to ensure the treatment protocol is designed for your specific situation rather than a generic protocol applied without individualization. Asking your clinic what specific aspects of your diagnostic picture are shaping their protocol recommendation is a reasonable and important question.

EMBRYO QUALITY AND TRANSFER STRATEGY

The number and quality of embryos available for transfer significantly affect outcomes. Modern embryology laboratories assess embryos based on developmental stage and morphology — the appearance and cellular organization of the embryo at the blastocyst stage. High-quality blastocysts have meaningfully better implantation rates than lower-quality embryos, though embryo grading is not a perfect predictor of any individual embryo's potential.

Single embryo transfer is increasingly the standard of care for good-prognosis patients — it reduces the risk of multiple pregnancies (which carry significant health risks) while maintaining strong success rates when the transferred embryo is of good quality. The decision about how many embryos to transfer is one to make explicitly with your reproductive endocrinologist based on your specific situation, not as a default assumption.

Frozen embryo transfer cycles — in which embryos from a previous stimulation cycle are transferred in a subsequent cycle with optimized endometrial preparation — have increasingly shown success rates comparable to or better than fresh transfers in many patient populations. The comparison between fresh and frozen transfer is worth discussing with your clinic in the context of your specific situation rather than assuming one is always preferable.

Preimplantation genetic testing for aneuploidies (PGT-A) screens embryos for chromosomal abnormalities before transfer. Evidence on whether PGT-A improves outcomes is more nuanced than it is sometimes presented. For some patient populations — particularly those with recurrent pregnancy loss or older women with concerns about chromosomal abnormalities — it may improve the likelihood that transferred embryos are chromosomally normal.

For others, the evidence of benefit is less clear. This is a conversation to have explicitly with your reproductive endocrinologist rather than assuming testing is always beneficial or never warranted.

LIFESTYLE FACTORS: WHAT THE EVIDENCE ACTUALLY SHOWS

Both partners' health and lifestyle genuinely matter for IVF outcomes, though the magnitude of specific effects and the evidence quality varies across different lifestyle factors. What the evidence most consistently supports: avoiding smoking (which is associated with reduced egg quality and sperm parameters — you may want to verify specific studies with your doctor), minimizing alcohol during treatment cycles, maintaining a healthy weight, getting adequate sleep, and managing chronic stress to the extent possible.

Nutrition is frequently discussed in the context of fertility, and there is genuine evidence suggesting that dietary patterns associated with lower inflammation — diets higher in vegetables, fruits, whole grains, healthy fats, and lean proteins — are associated with better reproductive outcomes in research published in journals including Human Reproduction Update and Fertility and Sterility. I cannot point you to specific studies with certainty, but your reproductive endocrinologist or a registered dietitian experienced with fertility can provide more specific guidance.

Supplements — CoQ10, omega-3s, vitamin D, folate, and others — are frequently discussed in the fertility context. The evidence base varies considerably by supplement and by whether the patient has a deficiency. Targeted supplementation under medical guidance, based on bloodwork identifying specific deficiencies, is more defensible than generic supplementation without a clinical basis. Always discuss supplements with your reproductive endocrinologist before starting them, as interactions with treatment medications are possible.

WHAT YOU CANNOT CONTROL — AND WHY THAT MATTERS

A significant portion of what determines IVF outcomes is beyond any individual's influence: the chromosomal health of individual eggs and embryos, the specific biological factors affecting implantation, and the inherent variability of reproductive biology. Understanding this is not defeatist. It is an important corrective to the common tendency — reinforced by the emphasis on lifestyle optimization — to attribute failed cycles to things the couple did wrong.

Most failed IVF cycles fail because of chromosomal abnormalities in the embryo or because of implantation factors that are not predictable or preventable. This is the honest biological reality, and couples who understand it tend to process failed cycles with somewhat less self-blame than those who do not — which is both emotionally healthier and more accurate.

REFLECT TOGETHER:

Identify one or two lifestyle areas where you both genuinely feel you can make changes that would be sustainable and that you'd feel good about — not everything at once, but something that feels real and doable. Then make a list of questions for your next appointment: about your specific prognosis, about what factors the clinic considers most important in your case, and about what they would recommend if the first cycle is unsuccessful. Going in with specific questions produces more useful information than going in to receive whatever the doctor volunteers.

Verification note: All success rate information should be verified against current CDC and SART annual reports at sart.org and cdc.gov/art. Evidence on specific lifestyle interventions and supplements varies in quality; consult your reproductive endocrinologist and, where relevant, a registered dietitian for guidance specific to your situation. My knowledge cutoff is August 2025 and some clinical guidance may have evolved.